Literature DB >> 25361925

Direct evidence of sirtuin downregulation in the liver of non-alcoholic fatty liver disease patients.

Tao Wu1, Yu-hua Liu1, Yu-cai Fu2, Xing-mu Liu3, Xiao-hui Zhou4.   

Abstract

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) has become the most common form of chronic liver disease in the world. Recent studies in cultured cells and mice have shown that sirtuin, especially sirtuin 1 (SIRT1), is a key metabolic sensor for regulating metabolic homeostasis and thus has the potential to ameliorate NAFLD. For the purposes of this study, we hypothesized that the inhibition of sirtuin signaling might contribute to the development of NAFLD.
METHODS: Tissue was obtained from hepatectomy specimens (10 samples), and medicolegal autopsies (10 samples). Liver tissue sections were stained with H&E. Expression of sirtuin in liver tissues in NAFLD and control group was investigated by RT-PCR and Western blotting.
RESULTS: RT-PCR and Western blotting demonstrated decreased expression of SIRT1, SIRT3, SIRT5, and SIRT6 in the NAFLD group in comparison with the control group. Increased expression of lipogenic genes including sterol regulatory element binding protein-1 (SREBP-1), fatty acid synthase (FASN), and acetyl-CoA carboxylase (ACC) was noted within the NAFLD group. In contrast to the other SIRT genes, the expression of SIRT4 was upregulated.
CONCLUSION: Our study provides direct evidence of the downregulation of sirtuin signaling that suppresses lipid synthesis in the liver of NAFLD patients, which may promote NAFLD development.
© 2014 by the Association of Clinical Scientists, Inc.

Entities:  

Keywords:  NAFLD; SIRT1; fatty liver; hepatic lipid metabolism; lipogenic genes; sirtuin

Mesh:

Substances:

Year:  2014        PMID: 25361925

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  45 in total

1.  Sirtuin 3 (SIRT3) Regulates α-Smooth Muscle Actin (α-SMA) Production through the Succinate Dehydrogenase-G Protein-coupled Receptor 91 (GPR91) Pathway in Hepatic Stellate Cells.

Authors:  Ying Hui Li; Dae Hee Choi; Eun Hye Lee; Su Ryeon Seo; Seungkoo Lee; Eun-Hee Cho
Journal:  J Biol Chem       Date:  2016-02-24       Impact factor: 5.157

2.  Generation of Human Fatty Livers Using Custom-Engineered Induced Pluripotent Stem Cells with Modifiable SIRT1 Metabolism.

Authors:  Alexandra Collin de l'Hortet; Kazuki Takeishi; Jorge Guzman-Lepe; Kazutoyo Morita; Abhinav Achreja; Branimir Popovic; Yang Wang; Kan Handa; Anjali Mittal; Noah Meurs; Ziwen Zhu; Frank Weinberg; Michael Salomon; Ira J Fox; Chu-Xia Deng; Deepak Nagrath; Alejandro Soto-Gutierrez
Journal:  Cell Metab       Date:  2019-08-06       Impact factor: 27.287

Review 3.  Mitochondrial Function, Metabolic Regulation, and Human Disease Viewed through the Prism of Sirtuin 4 (SIRT4) Functions.

Authors:  Cora N Betsinger; Ileana M Cristea
Journal:  J Proteome Res       Date:  2019-04-08       Impact factor: 4.466

Review 4.  The CD38 glycohydrolase and the NAD sink: implications for pathological conditions.

Authors:  Julianna D Zeidler; Kelly A Hogan; Guillermo Agorrody; Thais R Peclat; Sonu Kashyap; Karina S Kanamori; Lilian Sales Gomez; Delaram Z Mazdeh; Gina M Warner; Katie L Thompson; Claudia C S Chini; Eduardo Nunes Chini
Journal:  Am J Physiol Cell Physiol       Date:  2022-02-09       Impact factor: 4.249

5.  SIRT2 Deficiency Exacerbates Hepatic Steatosis via a Putative Role of the ER Stress Pathway.

Authors:  Helena Leal; João Cardoso; Patrícia Valério; Marta Quatorze; Vítor Carmona; Janete Cunha-Santos; Luís Pereira de Almeida; Cláudia Pereira; Cláudia Cavadas; Pedro Gomes
Journal:  Int J Mol Sci       Date:  2022-06-17       Impact factor: 6.208

Review 6.  NAFLD: Mechanisms, Treatments, and Biomarkers.

Authors:  Fatiha Nassir
Journal:  Biomolecules       Date:  2022-06-13

Review 7.  Sirtuins-Mediated System-Level Regulation of Mammalian Tissues at the Interface between Metabolism and Cell Cycle: A Systematic Review.

Authors:  Parcival Maissan; Eva J Mooij; Matteo Barberis
Journal:  Biology (Basel)       Date:  2021-03-04

8.  Downregulation of p16 Decreases Biliary Damage and Liver Fibrosis in the Mdr2/ Mouse Model of Primary Sclerosing Cholangitis.

Authors:  Konstantina Kyritsi; Heather Francis; Tianhao Zhou; Ludovica Ceci; Nan Wu; Zhihong Yang; Fanyin Meng; Lixian Chen; Leonardo Baiocchi; Debjyoti Kundu; Lindsey Kennedy; Suthat Liangpunsakul; Chaodong Wu; Shannon Glaser; Gianfranco Alpini
Journal:  Gene Expr       Date:  2020-05-11

Review 9.  Sirtuin deficiency and the adverse effects of fructose and uric acid synthesis.

Authors:  Bernardo Rodriguez-Iturbe; Richard J Johnson; Miguel A Lanaspa; Takahiko Nakagawa; Fernando E Garcia-Arroyo; Laura G Sánchez-Lozada
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2022-03-10       Impact factor: 3.619

10.  Genetic and Functional Sequence Variants of the SIRT3 Gene Promoter in Myocardial Infarction.

Authors:  Xiaoyun Yin; Shuchao Pang; Jian Huang; Yinghua Cui; Bo Yan
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.